Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

78.95
-8.2200-9.43%
Post-market: 78.86-0.0900-0.11%18:50 EDT
Volume:12.60M
Turnover:1.00B
Market Cap:350.46B
PE:25.13
High:80.70
Open:79.81
Low:78.30
Close:87.17
Loading ...

Novo Nordisk Q4 2024 GAAP EPS DKK 6.34 Beats DKK 5.82 Estimate, Sales DKK 85.683B Beat DKK 79.730B Estimate

Benzinga
·
05 Feb

Novo Nordisk Q4 Profit Beats Expectations, Sees Slower Growth in 2025

Reuters
·
05 Feb

Stock Track | Novo-Nordisk Soars 5.3% as Investors Anticipate Strong GLP-1 Drug Sales and Supply Updates

Stock Track
·
05 Feb

Novo Nordisk Earnings Must Show GLP-1 Market Still Set for Big Growth -- Barrons.com

Dow Jones
·
05 Feb

Merck Stock Plunges 9.5% After China Halt--Is This the Beginning of Bigger Trouble?

GuruFocus.com
·
05 Feb

Novo Nordisk on Lookout for Next-Generation Obesity Drug Candidates, The Wall Street Journal Reports

MT Newswires Live
·
05 Feb

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
05 Feb

Novo Nordisk Concludes Phase of Share Repurchase Program

TIPRANKS
·
04 Feb

Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results

Fortune
·
04 Feb

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
04 Feb

Jim Cramer Expects Novo Nordisk A/S (NVO) To Forecast A Good 2025

Insider Monkey
·
03 Feb

UBS Keeps Their Buy Rating on Novo Nordisk (0QIU)

TIPRANKS
·
03 Feb

Market Chatter: Novo Nordisk Foundation Won't Step In to Replace US Aid for Health Sector

MT Newswires Live
·
03 Feb

Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock?

Zacks
·
03 Feb

3 Magnificent Stocks to Buy and Hold Forever

Motley Fool
·
03 Feb

Novo Nordisk A/S expected to post earnings of DKK5.86 a share - Earnings Preview

Reuters
·
03 Feb